GPN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.014400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.659800E-01
Normal-vs-Stage2
4.935400E-01
Normal-vs-Stage3
8.636300E-02
Normal-vs-Stage4
4.342800E-01
Stage1-vs-Stage2
7.302200E-01
Stage1-vs-Stage3
1.122050E-01
Stage1-vs-Stage4
9.497400E-01
Stage2-vs-Stage3
2.197200E-01
Stage2-vs-Stage4
8.129200E-01
Stage3-vs-Stage4
1.134980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.496400E-01
Normal-vs-AfricanAmerican
3.583000E-01
Normal-vs-Asian
8.953900E-02
Caucasian-vs-AfricanAmerican
7.474800E-01
Caucasian-vs-Asian
5.246100E-02
AfricanAmerican-vs-Asian
2.714400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.548600E-01
Normal-vs-Female
4.368400E-01
Male-vs-Female
8.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.125050E-01
Normal-vs-Age(41-60Yrs)
8.454200E-01
Normal-vs-Age(61-80Yrs)
3.419400E-01
Normal-vs-Age(81-100Yrs)
6.537200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.042200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.574200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.303800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.486450E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.952600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.625000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.921800E-01
Normal-vs-Daily Drinker
3.780600E-01
Normal-vs-Weekly Drinker
4.736800E-01
Normal-vs-Occasional Drinker
9.411600E-01
Normal-vs-Social Drinker
6.164800E-01
Non Drinker-vs-Daily Drinker
7.703800E-01
Non Drinker-vs-Weekly Drinker
9.289800E-01
Non Drinker-vs-Occasional Drinker
9.533900E-02
Non Drinker-vs-Social Drinker
3.230800E-01
Daily Drinker-vs-Weekly Drinker
8.991200E-01
Daily Drinker-vs-Occasional Drinker
1.361610E-01
Daily Drinker-vs-Social Drinker
4.960200E-01
Weekly Drinker-vs-Occasional Drinker
2.085800E-01
Weekly Drinker-vs-Social Drinker
5.247200E-01
Occasional Drinker-vs-Social Drinker
4.156800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.979600E-01
Normal-vs-Grade 2
9.558400E-01
Normal-vs-Grade 3
8.967400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.563600E-01
Grade 1-vs-Grade 3
1.239610E-01
Grade 1-vs-Grade 4
9.979600E-01
Grade 2-vs-Grade 3
2.120400E-01
Grade 2-vs-Grade 4
9.558400E-01
Grade 3-vs-Grade 4
8.967400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.747200E-01
Normal-vs-NonDiabetic
4.915800E-01
Diabetic-vs-NonDiabetic
5.870200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.621500E-02
Normal-vs-NoPancreatitis
5.391800E-01
Pancreatitis-vs-NoPancreatitis
1.484360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.007200E-01
Normal-vs-N1
5.225600E-01
N0-vs-N1
8.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.742200E-01
Normal-vs-TP53-NonMutant
5.718800E-01
TP53-Mutant-vs-TP53-NonMutant
5.114600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
